• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Duearity

Less than 1K followers
All
Research
Press releases
ShowingAll content types

Press release10.03.2024 klo 14.43

Duearity has entered into an agreement with a national distributor in the USA

Duearity
Press release06.02.2024 klo 09.53

Clinics in the US can now purchase Tinearity G1 through a national trading platform

Duearity
Eminova Partners day - Duearity
Video15.01.2024 klo 13.34 by
Lucas Mattsson, Jesper Hagman

Eminova Partners day - Duearity

During the day with Eminova Partners, analyst Lucas Mattsson got the chance to interview Fredrik Westman, CEO of Duearity. The discussion includes Duearity as an investment, what the market looks like today and what the strategy for Duearity looks like in the future.

Duearity

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release20.12.2023 klo 09.50

Duearity's sales SEK 450,000 in December - the best month so far

Duearity
Regulatory press release02.10.2023 klo 12.11

Duearity AB has signed a distributor agreement - covering Belgium, the Netherlands and Luxembourg

Duearity
Press release25.08.2023 klo 11.29

Duearity Americas Inc has signed agreements with the first clinics in the United States

Duearity
Regulatory press release27.07.2023 klo 11.22

Duearity AB has signed a distributor agreement in Great Britain

Duearity
Press release05.06.2023 klo 09.00

Positive results from Duearity's user study on people with tinnitus

Duearity
Regulatory press release23.05.2023 klo 12.01

Duearity AB has signed a distributor agreement

Duearity
Regulatory press release26.04.2023 klo 15.52

The tinnitus product Tinearity G1 has received market approval in the UK

Duearity
Regulatory press release31.10.2022 klo 09.27

Duearity will submit an application for approval of a tinnitus product in the United States

Duearity
Regulatory press release02.11.2021 klo 09.41

Duearity to develop AI solution for people suffering from tinnitus

Duearity